Clinical trial
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not…
NCT00407719 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00407719 |
|---|---|
| Title | Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) |
| Official title | An Open-Label, Pilot Study of Bevacizumab in Subjects With Choroidal Neovascularization Secondary to Diseases Other Than Age-Related Macular Degeneration |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization, Degenerative Myopia, Pathological Myopia |
| Intervention type | Drug |
| Interventions | Bevacizumab |
| Enrollment | 10 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Dec 5, 2006 |
| Last update posted | Feb 3, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: